DK1305311T3 - Tartratsalt af thiazolidindionderivat - Google Patents

Tartratsalt af thiazolidindionderivat

Info

Publication number
DK1305311T3
DK1305311T3 DK01954159T DK01954159T DK1305311T3 DK 1305311 T3 DK1305311 T3 DK 1305311T3 DK 01954159 T DK01954159 T DK 01954159T DK 01954159 T DK01954159 T DK 01954159T DK 1305311 T3 DK1305311 T3 DK 1305311T3
Authority
DK
Denmark
Prior art keywords
tartrate salt
thiazolidinedione derivative
thiazolidinedione
derivative
tartrate
Prior art date
Application number
DK01954159T
Other languages
English (en)
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DK1305311T3 publication Critical patent/DK1305311T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/08Antibacterial agents for leprosy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Cosmetics (AREA)
DK01954159T 2000-08-04 2001-08-03 Tartratsalt af thiazolidindionderivat DK1305311T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0019224.5A GB0019224D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical
PCT/GB2001/003511 WO2002012232A1 (en) 2000-08-04 2001-08-03 Tartrate salt of thiazolidinedione derivative

Publications (1)

Publication Number Publication Date
DK1305311T3 true DK1305311T3 (da) 2008-05-19

Family

ID=9897026

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01954159T DK1305311T3 (da) 2000-08-04 2001-08-03 Tartratsalt af thiazolidindionderivat

Country Status (37)

Country Link
US (1) US20040014790A1 (da)
EP (1) EP1305311B1 (da)
JP (1) JP2004505970A (da)
KR (1) KR100755174B1 (da)
CN (1) CN1455778A (da)
AP (1) AP1785A (da)
AT (1) ATE384059T1 (da)
AU (1) AU2001276506A1 (da)
BG (1) BG107604A (da)
BR (1) BR0112982A (da)
CA (1) CA2417827A1 (da)
CY (1) CY1107252T1 (da)
CZ (1) CZ2003313A3 (da)
DE (1) DE60132461T2 (da)
DK (1) DK1305311T3 (da)
DZ (1) DZ3418A1 (da)
EA (1) EA005408B1 (da)
EC (1) ECSP034467A (da)
ES (1) ES2296772T3 (da)
GB (1) GB0019224D0 (da)
HK (1) HK1057358A1 (da)
HR (1) HRP20030068B1 (da)
HU (1) HUP0300778A3 (da)
IL (2) IL154275A0 (da)
MA (1) MA25832A1 (da)
MX (1) MXPA03001085A (da)
NO (1) NO324596B1 (da)
NZ (1) NZ524030A (da)
OA (1) OA12354A (da)
PL (1) PL360662A1 (da)
PT (1) PT1305311E (da)
SI (1) SI1305311T1 (da)
SK (1) SK1462003A3 (da)
UA (1) UA76720C2 (da)
WO (1) WO2002012232A1 (da)
YU (1) YU14603A (da)
ZA (1) ZA200300961B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
CN108348292B (zh) 2015-10-27 2021-04-27 纳诺帕斯技术有限公司 具有机械性导引的微针装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
ES2296772T3 (es) 2008-05-01
EA005408B1 (ru) 2005-02-24
PL360662A1 (en) 2004-09-20
DE60132461D1 (de) 2008-03-06
ZA200300961B (en) 2004-04-01
MXPA03001085A (es) 2003-05-27
HUP0300778A2 (hu) 2003-11-28
KR20030022355A (ko) 2003-03-15
IL154275A0 (en) 2003-09-17
HUP0300778A3 (en) 2005-04-28
SI1305311T1 (sl) 2008-04-30
YU14603A (sh) 2006-05-25
MA25832A1 (fr) 2003-07-01
AP2003002736A0 (en) 2003-03-31
NZ524030A (en) 2004-07-30
GB0019224D0 (en) 2000-09-27
HRP20030068B1 (en) 2008-07-31
HRP20030068A2 (en) 2005-02-28
JP2004505970A (ja) 2004-02-26
BR0112982A (pt) 2003-08-26
KR100755174B1 (ko) 2007-09-03
NO20030530L (no) 2003-02-03
ECSP034467A (es) 2003-03-31
CY1107252T1 (el) 2012-11-21
DE60132461T2 (de) 2008-12-24
WO2002012232A1 (en) 2002-02-14
EA200300230A1 (ru) 2003-06-26
BG107604A (bg) 2003-09-30
UA76720C2 (uk) 2006-09-15
NO324596B1 (no) 2007-11-26
DZ3418A1 (fr) 2002-02-14
EP1305311A1 (en) 2003-05-02
PT1305311E (pt) 2008-04-07
EP1305311B1 (en) 2008-01-16
OA12354A (en) 2004-03-19
HK1057358A1 (en) 2004-04-02
IL154275A (en) 2009-02-11
ATE384059T1 (de) 2008-02-15
CA2417827A1 (en) 2002-02-14
AU2001276506A1 (en) 2002-02-18
US20040014790A1 (en) 2004-01-22
CZ2003313A3 (cs) 2004-02-18
SK1462003A3 (en) 2004-06-08
NO20030530D0 (no) 2003-02-03
AP1785A (en) 2007-10-04
CN1455778A (zh) 2003-11-12

Similar Documents

Publication Publication Date Title
DK1438306T3 (da) Derivater af UK-2A
DK1360169T3 (da) Succinatsalt af O-desmethyl-venlafaxin
DE60223278D1 (de) Nicotin- oder isonicotin benzothiazole derivaten
ATE361281T1 (de) Substituierte phenylderivate
NO20025978D0 (no) Benzotiazol-derivater
ATE391505T1 (de) Benzothiazole derivative
NO20025659L (no) Heterocykliske forbindelser
PT1322592E (pt) Derivados substituidos de 1-aminobutan-3-ol
DK1305312T3 (da) Tartratsalte af thiazolidindionderivat
DE60031450D1 (de) Polymorph v von torasemid
DK1305311T3 (da) Tartratsalt af thiazolidindionderivat
NO20030508L (no) Tartratsalter av tiazolidindionderivater
DK1305310T3 (da) Tartratsalte af thiazolidindionderivater
DE60219659D1 (de) Heterocyclische retioidverbindungen
SI1305310T1 (sl) Tartratne soli derivata tiazolidindiona